Bahrain Mumtalakat Holding Company

Bahrain Mumtalakat Holding Company (Mumtalakat) is the sovereign wealth fund of the Kingdom of Bahrain, established in 2006 to manage the state's non-oil assets. The company maintains a diverse investment portfolio across various sectors, with a strategic emphasis on healthcare, life sciences, and pharmaceutical manufacturing. Through its subsidiaries and affiliates, such as Gulf Biotech and Bahrain Pharma, Mumtalakat is instrumental in developing regional capabilities for vaccine production and specialized drug manufacturing. The fund's healthcare strategy aims to enhance the quality of medical services in Bahrain while fostering a robust ecosystem for biotechnology innovation. Mumtalakat operates as an active investor, seeking long-term value creation through both domestic projects and international partnerships. Its life sciences investments are focused on achieving pharmaceutical self-sufficiency and addressing unmet medical needs within the Middle East and North Africa region.